A randomized study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Drummond, Michael B ^a   Astemborski, Jacquie ^b   Lambert, Allison A ^a   Goldberg, Scott ^c   Stitzer, Maxine L ^a   Merlo, Christian A ^a   Rand, Cynthia S ^a   Wise, Robert A ^a   Kirk, Gregory D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Contingency management; Lung age; Smoking cessation; Spirometry

Indexed keywords

COHORT ANALYSIS; COMPLICATION; CONTROLLED STUDY; COUNSELING; DRUG USE; FEMALE; HEALTH BEHAVIOR; HUMAN; LUNG; MALE; MIDDLE AGED; MOTIVATION; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SPIROMETRY; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; TOBACCO USE DISORDER; TREATMENT OUTCOME; UNITED STATES;

BALTIMORE; COHORT STUDIES; COUNSELING; DRUG USERS; FEMALE; HEALTH BEHAVIOR; HUMANS; LUNG; MALE; MIDDLE AGED; MOTIVATION; SMOKING CESSATION; SPIROMETRY; SUBSTANCE ABUSE, INTRAVENOUS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84904772103     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-761     Document Type: Article

References (65)

1. Effect of cigarette smoking on HIV acquisition, progression, and mortality. Marshall MM, McCormack MC, Kirk GD, AIDS Educ Prev 2009 21 3 Suppl 28 39
2. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Darke S, Hall W, Drug Alcohol Depend 1995 39 3 231 235
3. Current perspectives on smoking cessation among substance abusers. Sullivan MA, Covey LS, Curr Psychiatry Rep 2002 4 5 388 396
4. HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Kirk GD, Merlo CA, Proc Am Thorac Soc 2011 8 3 326 332
5. Smoking habits and attitudes in a methadone maintenance treatment population. Clemmey P, Brooner R, Chutuape MA, Kidorf M, Stitzer M, Drug Alcohol Depend 1997 44 2-3 123 132
6. Smoking in 6 diverse Chicago communities-a population study. Dell JL, Whitman S, Shah AM, Silva A, Ansell D, Am J Public Health 2005 95 6 1036 1042
7. Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000. Barbeau EM, Krieger N, Soobader MJ, Am J Public Health 2004 94 2 269 278
8. What accounts for the relationship between social class and smoking cessation? Results of a path analysis. Honjo K, Tsutsumi A, Kawachi I, Kawakami N, Soc Sci Med 2006 62 2 317 328
9. Psychosocial predictors of nicotine dependence in Black and Puerto Rican adults: a longitudinal study. Brook JS, Brook DW, Zhang C, Nicotine Tob Res 2008 10 6 959 967
10. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Kanjilal S, Gregg EW, Cheng YJ, Zhang P, Nelson DE, Mensah G, Beckles GL, Arch Intern Med 2006 166 21 2348 2355
11. Interest in smoking cessation among injection drug users. Clarke JG, Stein MD, McGarry KA, Gogineni A, Am J Addict 2001 10 2 159 166
12. Cigarette smoking and methadone dose levels. Stark MJ, Campbell BK, Am J Drug Alcohol Abuse 1993 19 2 209 217
13. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Frosch DL, Shoptaw S, Nahom D, Jarvik ME, Exp Clin Psychopharmacol 2000 8 1 97 103
14. Higgins ST, Contingency management in substance abuse treatment New York: Guilford Press 2007
15. The bottom line on cash incentives with drug users. Vlahov D, Strathdee S, Addiction 2009 104 5 796 797
16. Examination of contingency payments to dually-diagnosed patients in a multi-faceted behavioral treatment. Strong Kinnaman JE, Slade E, Bennett ME, Bellack AS, Addict Behav 2007 32 7 1480 1485
17. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Iguchi MY, Stitzer ML, Bigelow GE, Liebson IA, Drug Alcohol Depend 1988 22 1-2 1 7
18. Contingent take-home incentive: effects on drug use of methadone maintenance patients. Stitzer ML, Iguchi MY, Felch LJ, J Consult Clin Psychol 1992 60 6 927 934
19. Improving substance abuse treatment enrollment in community syringe exchangers. Kidorf M, King VL, Neufeld K, Peirce J, Kolodner K, Brooner RK, Addiction 2009 104 5 786 795
20. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Dunn KE, Sigmon SC, Reimann EF, Badger GJ, Heil SH, Higgins ST, Exp Clin Psychopharmacol 2010 18 1 37 50
21. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. Dunn KE, Sigmon SC, Thomas CS, Heil SH, Higgins ST, J Appl Behav Anal 2008 41 4 527 538
22. Contingency management promotes smoking reductions in residential substance abuse patients. Alessi SM, Petry NM, Urso J, J Appl Behav Anal 2008 41 4 617 622
23. A randomized controlled trial of financial incentives for smoking cessation. Volpp KG, Gurmankin Levy A, Asch DA, Berlin JA, Murphy JJ, Gomez A, Sox H, Zhu J, Lerman C, Cancer Epidemiol Biomarkers Prev 2006 15 1 12 18
24. A randomized, controlled trial of financial incentives for smoking cessation. Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, Galvin R, Zhu J, Wan F, DeGuzman J, Corbett E, Weiner J, Audrain-McGovern J, N Engl J Med 2009 360 7 699 709
25. Spirometric lung age estimation for motivating smoking cessation. Morris JF, Temple W, Prev Med 1985 14 5 655 662
26. The effects of providing lung age and respiratory symptoms feedback on community college smokers' perceived smoking-related health risks, worries and desire to quit. Lipkus IM, Prokhorov AV, Addict Behav 2007 32 3 516 532
27. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, Solomon L, Polk BF, NIDA Res Monogr 1991 109 75 100
28. Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Marshall MM, Kirk GD, Caporaso NE, McCormack MC, Merlo CA, Hague JC, Mehta SH, Engels EA, Addict Behav 2011 36 1-2 61 67
29. HIV and COPD: impact of risk behaviors and diseases on quality of life. Drummond MB, Kirk GD, McCormack MC, Marshall MM, Ricketts EP, Mehta SH, Wise RA, Merlo CA, Qual Life Res 2010 19 9 1295 1302
30. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H, JAMA 1998 279 1 35 40
31. Contingency management for tobacco smoking in methadone-maintained opiate addicts. Shoptaw S, Jarvik ME, Ling W, Rawson RA, Addict Behav 1996 21 3 409 412
32. Standardisation of spirometry. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J for the ATS/ERS Task Force, Eur Respir J 2005 26 2 319 338
33. Spirometric reference values from a sample of the general U.S. population. Hankinson JL, Odencrantz JR, Fedan KB, Am J Respir Crit Care Med 1999 159 1 179 187
34. The measurement of exhaled carbon monoxide in healthy smokers and non-smokers. Deveci SE, Deveci F, Acik Y, Ozan AT, Respir Med 2004 98 6 551 556
35. Stages and processes of self-change of smoking: toward an integrative model of change. Prochaska JO, DiClemente CC, J Consult Clin Psychol 1983 51 3 390 395
36. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO, Br J Addict 1991 86 9 1119 1127
37. Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Wagenknecht LE, Burke GL, Perkins LL, Haley NJ, Friedman GD, Am J Public Health 1992 82 1 33 36
38. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST, Addiction 2006 101 2 192 203
39. Contingency management: utility in the treatment of drug abuse disorders. Stitzer ML, Vandrey R, Clin Pharmacol Ther 2008 83 4 644 647
40. Contingency management in outpatient methadone treatment: a meta-analysis. Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD, Drug Alcohol Depend 2000 58 1-2 55 66
41. Contingency management for treatment of substance use disorders: a meta-analysis. Prendergast M, Podus D, Finney J, Greenwell L, Roll J, Addiction 2006 101 11 1546 1560
42. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R, Arch Gen Psychiatry 2006 63 2 201 208
43. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R, Arch Gen Psychiatry 2005 62 10 1148 1156
44. Contingency management and the addictions. Stitzer M, Addiction 2006 101 11 1536 1537
45. Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives. Stitzer ML, Polk T, Bowles S, Kosten T, Drug Alcohol Depend 2010 107 1 76 79
46. Randomized trial of drug abuse treatment-linkage strategies. Sorensen JL, Masson CL, Delucchi K, Sporer K, Barnett PG, Mitsuishi F, Lin C, Song Y, Chen T, Hall SM, J Consult Clin Psychol 2005 73 6 1026 1035
47. The effect of financial incentives on adherence with outpatient human immunodeficiency virus testing referrals from the emergency department. Haukoos JS, Witt MD, Coil CJ, Lewis RJ, Acad Emerg Med 2005 12 7 617 621
48. The Demand for, and Impact of Learning HIV Status. Thornton R, Am Econ Rev 2008 98 5 1829 1863
49. Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers. Rogers RE, Higgins ST, Silverman K, Thomas CS, Badger GJ, Bigelow G, Stitzer M, Psychol Addict Behav 2008 22 4 544 550
50. Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Schroeder JR, Epstein DH, Umbricht A, Preston KL, Addict Behav 2006 31 5 868 879
51. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, Veniegas RC, Freese TE, Hucks-Ortiz C, Drug Alcohol Depend 2005 78 2 125 134
52. Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection. Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD, J Acquir Immune Defic Syndr Hum Retrovirol 1996 11 5 455 459
53. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S, Drug Alcohol Depend 2007 88 1 54 63
54. Group-based randomized trial of contingencies for health and abstinence in HIV patients. Petry NM, Weinstock J, Alessi SM, Lewis MW, Dieckhaus K, J Consult Clin Psychol 2010 78 1 89 97
55. Does assigning a representative payee reduce substance abuse? Rosen MI, McMahon TJ, Rosenheck R, Drug Alcohol Depend 2007 86 2-3 115 122
56. A Preliminary Randomized Controlled Trial of a Nurse-Delivered Medication Adherence Intervention Among HIV-Positive Outpatients Initiating Antiretroviral Therapy in Beijing, China. Simoni JM, Chen WT, Huh D, Fredriksen-Goldsen KI, Pearson C, Zhao H, Shiu CS, Wang X, Zhang F, AIDS Behav 2010 15 5 919 929
57. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. Parkes G, Greenhalgh T, Griffin M, Dent R, BMJ 2008 336 7644 598 600
58. The Health Belief Model: a decade later. Janz NK, Becker MH, Health Educ Q 1984 11 1 1 47
59. Experimental evidence for stages of health behavior change: the precaution adoption process model applied to home radon testing. Weinstein ND, Lyon JE, Sandman PM, Cuite CL, Health Psychol 1998 17 5 445 453
60. Cognitive and physiological processes in fear appeals and the attitude change: A revised theory of protection motivation. Rogers RW, Social psychosocialphysiology: A sourcebook New York: Guilford, Petty JTCRE, 1983 153 176
61. Self-initiated smoking cessation among high school students. Hansen WB, Collins LM, Johnson CA, Graham JW, Addict Behav 1985 10 3 265 271
62. Perceived invulnerability and cigarette smoking among adolescents. Milam JE, Sussman S, Ritt-Olson A, Dent CW, Addict Behav 2000 25 1 71 80
63. Do adolescents appreciate the risks of smoking? Evidence from a national survey. Romer D, Jamieson P, J Adolesc Health 2001 29 1 12 21
64. Prospective predictors of quit attempts and smoking cessation in young adults. Rose JS, Chassin L, Presson CC, Sherman SJ, Health Psychol 1996 15 4 261 268
65. A randomized controlled trial to assess the efficacy of an interactive mobile messaging intervention for underserved smokers: Project ACTION. Vidrine DJ, Fletcher FE, Danysh HE, Marani S, Vidrine JI, Cantor SB, Prokhorov AV, BMC Public Health 2012 12 696